PanTracer™ Tissue and Liquid Biopsy are available for #pharma partners to provide pan-tumor, comprehensive genomic profiling across both tissue and liquid biopsy. Learn more: neogenomics.com/PanTracer-LDT

Two samples, one story: Meet PanTracer™, the future of CGP in oncology. neogenomics.com/providers/onco…

#NeoGenomics is a sponsor of ASCO Direct™ Denver! Make plans to visit us and learn about our #oncology solutions for solid tumors, hematological cancers, and more. We’ll see you July 26 and 27 in Denver, #Colorado.

#Breakthroughs25 kicks off today! Visit us at our booth to see how we're helping #oncologists drive smarter, more personalized solutions.

#Breakthroughs25 is underway in National Harbor, MD. Visit #NeoGenomics at booth #1617 to see how we're helping #oncologists drive smarter, more personalized solutions.

Thank you to everyone who visited us during #Breakthroughs25! We enjoyed the great conversations and look forward to continuing the momentum.

#NeoGenomics is a sponsor of ASCO Direct™ Denver! Make plans to visit us and learn about our #oncology solutions for solid tumors, hematological cancers, and more. We’ll see you July 26 and 27 in Denver, #Colorado.

Sarcoma is rare—and accurate testing is critical. #NeoGenomics offers advanced testing solutions to help guide care for soft tissue and bone sarcomas. Explore our Sarcoma Comprehensive NGS Fusion Panel: neogenomics.com/providers/test…

NeoGenomics is attending the 2025 Oncology Clinical Updates conference in Napa Valley, CA, August 2–3. Stop by our table at the Hyatt Regency Sonoma Wine Country—we’d love to connect! 🔗 totalhealthoncology.com

The HealthTrust University Conference is August 18-20 at the Henry B. Gonzalez Convention Center in San Antonio, Texas. Find #NeoGenomics at booth #836!

PanTracer LBx provides minimally invasive, guideline-driven testing for over 500 genes, with results delivered within 7 days to enable real-time decision-making. Improving patient care is only a click away: neogenomics.com/providers/test…

Lung cancer demands precision. Comprehensive #GenomicProfiling can reveal actionable insights and targeted therapy options. Explore our comprehensive tissue and #LiquidBiopsy solutions: neogenomics.com/providers/onco…

Claudin18.2 may have been on your radar for years – and now, it’s an actionable target. We are proud to be one of the leading labs offering Claudin18.2 testing. Ready to put Claudin 18 FDA (VYLOY®) for Gastric/GEJ Adenocarcinoma into practice? Learn more: neogenomics.com/providers/onco…

We’re excited to connect at the HealthTrust University Conference! Discover the full breadth of our solutions and see how #NeoGenomics can be a valuable partner for HealthTrust members.

It has been great connecting with everyone at the HealthTrust University Conference in San Antonio! Thank you to everyone who has stopped by booth #836 to meet the #NeoGenomics team and explore how our solutions can support HealthTrust members.

#NeoGenomics colleagues have been in San Antonio, Texas, for the HealthTrust University Conference. We appreciated the opportunity to share with HealthTrust members how our comprehensive solutions make us a trusted partner.

NeoGenomics gives you needed insights to develop, refine & commercialize therapies that can change patient lives. 💡Smarter development 🚀 Faster market entry 📊 More confident decisions Let’s talk about how we can support your next oncology breakthrough: neogenomics.com/oncology-data-…